Anavex Life Sciences Corp (AVXL)

[falconer66a]

Interesting video presentation.

Thank you for bringing this to our attention.

The exact molecule used to suppress prion generation in the selected mice was not described. I saw no indication that this is any of the Anavex pipeline molecules or an Anavex 2-73 analogue.

That's of little consequence. Should Anavex, then, develop a safe, efficacious treatment for this variant of Creutzfeldt-Jakob Disease, well and good, particularly for the, now, very few who become afflicted with it.

Fortunately, CJD has not, as formerly feared, expanded or proliferated. Quite to the contrary. The disease (as I indicated) is now well-controlled in both hospitals and human food sources and rather rare. It is no longer a major medical concern (and not a major revenue-generating Anavex target).

And this is not to discount in any way the presenter's professional competence in protein neurotoxins. That expertise, should it be in the Anavex portfolio, can facilitate associated neuron research at the company.